By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
DrugPatentWatch Database Preview
Mechanism of Action: Cytochrome P450 1A2 Inhibitors
Email this page to a colleague
Drugs with Mechanism of Action: Cytochrome P450 1A2 Inhibitors
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | INJECTABLE;INJECTION | 075761-001 | Oct 15, 2002 | AP | RX | No | Yes | Get Started Free | Get Started Free | Get Started Free | |||
| Hikma Farmaceutica | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | INJECTABLE;INJECTION | 077234-001 | Feb 25, 2008 | AP | RX | No | No | Get Started Free | Get Started Free | Get Started Free | |||
| Murty Pharms | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | TABLET;ORAL | 077069-001 | Apr 8, 2005 | AB | RX | No | No | Get Started Free | Get Started Free | Get Started Free | |||
| Mayne Pharma Inc | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | TABLET;ORAL | 075389-001 | Jan 25, 2001 | AB | RX | No | No | Get Started Free | Get Started Free | Get Started Free | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
